Clinical trial · Observational
Detection of Electrodermal Activity in Pain 2
Detection of Electrodermal Activity in Pain (DEEP)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this study is to investigate the association between self-reported pain and electrodermal activity and to create an algorithm that detects pain and provides timely alarms for rising pain levels in patients with life-threatening illnesses suffering from persistent pain. The study is exploratory. Hypothesis: Electrodermal activity can distinguish different pain intensity levels in patients with chronic pain and a life-threatening disease. Methodology: Thirty-seven patients with cancer and/or chronic obstructive pulmonary disease (COPD) will be identified through hospital record screening. These patients will wear a monitoring device for a maximum of one week and report their pain intensity throughout the day. Analysis: Discriminant analysis will be used to differentiate between mild, moderate, and severe pain. This study is exploratory, generating hypotheses for subsequent phases of the project.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Chronic Obstructive Pulmonary Disease (COPD | — | UNRESOLVED | — |
| Pain | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Patients
- description
- Patients with COPD or cancer
Primary outcomes (1)
- measure
- Pain intensity
- timeFrame
- while participants wear the device (up to 7 days)
- description
- Numerical rating scale score. Pain intensity (interval, 0 to 10) is measured using the NRS, a commonly used tool asking patients to rate their pain intensity on a scale from 0 to 10, with 0 indicating no pain and 10 reflecting the worst possible pain.
Secondary outcomes (6)
- measure
- Skin conductance level
- timeFrame
- while participants wear the device (up to 7 days)
- description
- The average skin conductance value (μS) for 10 seconds.
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Danish * Age over 18 * Persistent or recurrent pain (longer than three months) * Cancer: DC01-DC9 or Pulmonary Diseases:DJ40-DJ47 Exclusion Criteria: * A current diagnosis with psychological/ psychiatric disorders * Impaired cognitive function * Substance abuse * A skin condition on the to-be-tested body parts * PHQ-9 reveals suicidal ideation
References
Publications (0)
Data not yet available